| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI112430 |
| P8608 | Fatcat ID | release_fen5tmssozh6hnyz56g3jthpg4 |
| P932 | PMC publication ID | 424474 |
| P698 | PubMed publication ID | 3007578 |
| P2093 | author name string | A Girolami | |
| T S Zimmerman | |||
| Z M Ruggeri | |||
| L De Marco | |||
| P2860 | cites work | CONSIDERATIONS ON PROLONGATION OF BLEEDING TIME IN CONGENITAL AFIBRINOGENEMIA | Q76646299 |
| Specific roles for platelet surface glycoproteins in platelet function | Q33339641 | ||
| Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis | Q33463842 | ||
| An Abnormal Platelet Glycoprotein Pattern in Three Cases of Glanzmann's Thrombasthenia | Q33463846 | ||
| Cycles of Agglutination-Disagglutination Induced by Ristocetin in Thrombasthenic Platelets | Q33473264 | ||
| Relationship between fibrinogen binding and the platelet glycoprotein deficiencies in Glanzmann's thrombasthenia type I and type II. | Q33478516 | ||
| Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent | Q33481601 | ||
| Platelet retention in glass bead columns: adhesion to glass and subsequent platelet-platelet interactions | Q33492356 | ||
| Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
| A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa | Q33821916 | ||
| Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody | Q34565552 | ||
| Interaction of von Willebrand factor with human platelets in the plasma milieu | Q34602783 | ||
| Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion | Q34619713 | ||
| Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation | Q34624945 | ||
| Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets | Q35204377 | ||
| Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets | Q36314768 | ||
| Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets | Q36983829 | ||
| Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation | Q37554183 | ||
| Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody | Q37609861 | ||
| Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin | Q37690541 | ||
| 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases | Q39433082 | ||
| Platelets and von Willebrand disease | Q39848774 | ||
| Inhibition of von Willebrand factor–platelet interaction by fibrinogen | Q41559907 | ||
| Human platelets possess an inducible and saturable receptor specific for fibrinogen | Q41629256 | ||
| Congenital afibrinogenemia. A case report with some considerations on the hereditary transmission of this disorder | Q47738258 | ||
| Adenosine diphosphate induces binding of von Willebrand factor to human platelets | Q59095973 | ||
| Immunoradiometric Assay of Factor VIII Related Antigen, with Observations in 32 Patients with von Willebrand's Disease | Q66883940 | ||
| Platelet adhesiveness and aggregation in congenital afibrinogenemia. An investigation of three patients with post-transfusion, cross-correction studies between two of them | Q66908523 | ||
| Metabolism and function of human platelets washed by albumin density gradient separation | Q67584447 | ||
| Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology | Q69899185 | ||
| The role of ADP secretion and thromboxane synthesis in factor VIII binding to platelets | Q70436666 | ||
| A report of a case of congenital afibrinogenemia | Q70448317 | ||
| Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes | Q71604615 | ||
| Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia | Q71787277 | ||
| Platelet function in congenital afibrinogenemia | Q72654398 | ||
| Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin | Q72824712 | ||
| Aggregation, adhesion, and viscous metamorphosis of platelets in congenital fibrinogen deficiencies | Q72868848 | ||
| THE PREPARATION AND SOME PROPERTIES OF FIBRINOGEN PRECIPITATED FROM HUMAN PLASMA BY GLYCINE | Q76588314 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| congenital disorder | Q727096 | ||
| P304 | page(s) | 1272-1277 | |
| P577 | publication date | 1986-04-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia | |
| P478 | volume | 77 |
| Q38360072 | A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment. |
| Q67905174 | A monoclonal antibody to a 67 kD cell membrane glycoprotein directly induces persistent platelet aggregation independently of granule secretion |
| Q34125159 | Adenosine diphosphate-induced aggregation of human platelets in flow through tubes. II. Effect of shear rate, donor sex, and ADP concentration |
| Q42971426 | Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha |
| Q30442274 | Adhesive ligand binding to integrin alpha IIb beta 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK |
| Q83025477 | Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized |
| Q36407213 | Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen. |
| Q38862618 | Congenital afibrinogenemia: from etiopathogenesis to challenging clinical management |
| Q34260216 | Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa |
| Q91852360 | Domain-specific mechanical modulation of VWF-ADAMTS13 interaction |
| Q33492095 | EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. |
| Q73919055 | Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin |
| Q42689568 | Evaluation of platelet surface glycoproteins in patients with Glanzmann thrombasthenia: Association with bleeding symptoms. |
| Q34554656 | Fibrin induces release of von Willebrand factor from endothelial cells |
| Q34564820 | Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate |
| Q37244598 | Glanzmann's thrombasthenia with mild von Willebrand's disease |
| Q33873826 | In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall |
| Q33446717 | Increased factor VIII/vWf levels in patients with reduced platelet number. |
| Q37393216 | Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets |
| Q37711750 | Integrin structure and function in hemostasis and thrombosis |
| Q34549309 | Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation |
| Q28287771 | Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations |
| Q44408524 | Novel effect of cyclicization of the Arg-Gly-Asp-containing peptide on vitronectin binding to platelets |
| Q40716742 | Old concepts and new developments in the study of platelet aggregation |
| Q28588951 | Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen |
| Q90441308 | Physiological Roles of the von Willebrand Factor-Factor VIII Interaction |
| Q74551383 | Platelet aggregation in flow: differential roles for adhesive receptors and ligands |
| Q38666940 | Platelet membrane glycoproteins and their function: an overview |
| Q47367663 | Platelet size distribution measurements as indicators of shear stress-induced platelet aggregation |
| Q35814524 | RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model |
| Q33852077 | Rapid platelet accumulation leading to thrombotic occlusion |
| Q29027960 | Resolution of fibrinogen deficiency in a patient with congenital afibrinogenemia after liver transplantation |
| Q71995270 | Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice |
| Q40656704 | Shear stress augments the enhanced adhesive phenotype of cells expressing the Pro33 isoform of integrin beta3. |
| Q37346480 | Structure and function of von Willebrand factor: relationship to von Willebrand's disease |
| Q47776991 | The Membrane Glycoprotein IIb/IIIa Complex Mediates Deposition of Thrombin-stimulated Blood Platelets on Polystyrene Plastic Under Static Conditions |
| Q36717020 | The Molecular Biology of Platelet Membrane Glycoproteins |
| Q41527357 | The platelet glycoprotein IIb/IIIa-like protein in human endothelial cells promotes adhesion but not initial attachment to extracellular matrix |
| Q34182746 | The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress |
| Q73069293 | Thrombocytopenia in pregnancy |
| Q33659450 | Thrombosis in Inherited Fibrinogen Disorders. |
| Q90460233 | Time-dependent interactions of blood platelets and cancer cells, accompanied by extramedullary hematopoiesis, lead to increased platelet activation and reactivity in a mouse orthotopic model of breast cancer - implications for pulmonary and liver me |
| Q37388583 | Treatment of congenital fibrinogen deficiency: overview and recent findings |
| Q35577294 | Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors |
| Q47776684 | Vitronectin inhibits blood platelet aggregation |
| Q34530389 | Von Willebrand factor and von Willebrand disease |
| Q45297966 | Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb |
| Q73038813 | [Therapy of acute coronary syndrome. Aspirin, heparin, low-molecular-weight heparin, hirudin and GP-IIb/IIIa blockers] |
| Q67276057 | von Willebrand disease |
| Q41043544 | von Willebrand disease: pathogenesis, classification, and management |
| Q37711736 | von Willebrand factor and platelet function |
| Q38687794 | von Willebrand factor and platelet function |
Search more.